Pathnostics to Present New Real-World Data Analysis of its Guidance® UTI Precision Diagnostic Test at the 2022 American Urology Association Annual Meeting

Analysis of Medicare Claims Data Compares Guidan

Analysis of Medicare Claims Data Compares Guidance UTI to Standard Urine Culture Among Patients with Complicated Urinary Tract Infections IRVINE, Calif., May 10, 2022 /PRNewswire/ — Pathnostics, a leading precision diagnostic testing and development company, today announced that it will…

Read the entire article here.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.